THURSDAY, March 2, 2023 (HealthDay News) — Premature births dropped during lockdowns in the early months of the COVID-19 pandemic. A groundbreaking study, which included a group of mostly high-income countries — including the United States, Belgium, Canada, Chile, Denmark and Switzerland — found there were about 4% fewer pretermContinue Reading
THURSDAY, March 2, 2023 (HealthDay News) — People who have long COVID — lingering symptoms after a COVID-19 infection — may also have lower brain oxygen levels, cognitive problems and psychiatric troubles, such as anxiety and depression. Researchers from the University of Waterloo in Canada and Drexel University in PhiladelphiaContinue Reading
THURSDAY, March 2, 2023 (HealthDay) — Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real. In a small new study of 16 people who said they’d experienced an allergic reaction to aContinue Reading
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in Americans ages 60 and older. The panel’s recommendation was based largelyContinue Reading
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed by pharmaceutical giant Pfizer Inc. The sameContinue Reading
MONDAY, Feb. 27, 2023 (HealthDay News) — Public health officials are warning about an increase in drug-resistant strains of the bacteria shigella. About 5% of shigella infections reported to the U.S. Centers for Disease Control and Prevention last year were caused by the drug-resistant XDR strain. That compares to 0%Continue Reading
MONDAY, Feb. 27, 2023 (HealthDay News) – A new at-home test will help people struggling with upper respiratory symptoms figure out whether they have COVID-19 or the flu. The U.S. Food and Drug Administration approved Lucira under an emergency use authorization (EUA) on Friday. “Today’s authorization of the first OTCContinue Reading
THURSDAY, Feb. 23, 2023 (HealthDay News) — Having the lingering symptoms known as long COVID after a COVID-19 infection more than doubles the risk of developing new heart symptoms, according to new research. “COVID-19 is more than a simple respiratory disease — it is a syndrome that can affect theContinue Reading
WEDNESDAY, Feb. 22, 2023 (HealthDay News) – The mpox virus — formerly known as monkeypox — often causes severe illness and death in those with advanced HIV infection that is not under control, researchers report. What does that mean? All people diagnosed with mpox should also be tested for HIV,Continue Reading
TUESDAY, Feb. 21, 2023 (HealthDay News) — Could a quick-dissolving pill placed in the rectum prove to be an effective and safe “on-demand” way to prevent HIV infection among sexually active men and women? It might, new research indicates. The experimental form of PrEP (pre-exposure prophylaxis) is designed to beContinue Reading